iEmoji Feeds @Santhosh Ambika (RenoHemonc)

1.

RenoHemonc
Santhosh Ambika @RenoHemonc
@hoperugo’s “Roadmap for Early Triple Negative Breast Cancer” #SGBCC2023
Retweet of status by @DrSGraff
17 Mar 23 copy & paste +upvote -downvote 🗺️ @hoperugo’s “Roadmap for Early Triple Negative Breast Cancer” #SGBCC2023 https://t.co/EngrqthF4F

2.

RenoHemonc
Santhosh Ambika @RenoHemonc
Very young women do poorly from #Breastcancer . Here we characterise oncogenic drivers from >1200 patients BC sa… twitter.com/i/web/status/1…
Retweet of status by @LoiSher
04 Feb 23 copy & paste +upvote -downvote 🚩Very young women do poorly from #Breastcancer 🤔. Here we characterise oncogenic drivers from >1200 patients BC sa… https://t.co/ISY42cWygM
3.
RenoHemonc
Santhosh Ambika @RenoHemonc
What to do when admitting a patient with lower GI bleeding

New, awesome guidelines from @SenguptaNeil
CTA if ong… twitter.com/i/web/status/1…
Retweet of status by @ebtapper
04 Feb 23 copy & paste +upvote -downvote What to do when admitting a patient with lower GI bleeding 🔥New, awesome guidelines from @SenguptaNeil 🔥CTA if ong… https://t.co/YuTfWnizK0
4.
RenoHemonc
Santhosh Ambika @RenoHemonc
new @myESMO #lungcancer guidelines for #biomarker driven therapies. 10 genomic alterations + more on the horizon… twitter.com/i/web/status/1…
Retweet of status by @christine_lovly
23 Jan 23 copy & paste +upvote -downvote ⬇️ new @myESMO #lungcancer guidelines for #biomarker driven therapies. 10 genomic alterations + more on the horizon… https://t.co/mmKoiYlW1t
5.
RenoHemonc
Santhosh Ambika @RenoHemonc
longer follow up (3 years) continues to show ctDNA is strongly associated with relapse (HR=6) and a 40% risk of… twitter.com/i/web/status/1…
Retweet of status by @tompowles1
05 Jul 22 copy & paste +upvote -downvote longer follow up (3 years) continues to show ctDNA is strongly associated with relapse (HR=6) and a 40% ⬇️ risk of… https://t.co/QsF1Q5HinM
6.
RenoHemonc
Santhosh Ambika @RenoHemonc
#OpenAccess Consensus Statement A clinical care pathway for von Hippel–Lindau (VHL) disease management develop… twitter.com/i/web/status/1…
Retweet of status by @VivekSubbiah
19 May 22 copy & paste +upvote -downvote 📍🚨 #OpenAccess Consensus Statement 👉🏼A clinical care pathway for von Hippel–Lindau (VHL) disease management develop… https://t.co/gsybvbB4YX
7.
RenoHemonc
Santhosh Ambika @RenoHemonc
MSH6
️Pathogenic variants in MSH6 cause #LynchSyndrome
️Lifetime #colorectalcancer risk is 10-44%
️Colonoscopy e… twitter.com/i/web/status/1…
Retweet of status by @HHampel1
13 Mar 22 copy & paste +upvote -downvote MSH6 ⚕️Pathogenic variants in MSH6 cause #LynchSyndrome ⚕️Lifetime #colorectalcancer risk is 10-44% ⚕️Colonoscopy e… https://t.co/ozbRZ11dtF
8.
RenoHemonc
Santhosh Ambika @RenoHemonc
Thrilled to announce that our paper is out @NatureMedicine!

We looked at the impact of nivolumab/ipilimumab +/-… twitter.com/i/web/status/1…
Retweet of status by @NazliDizman
28 Feb 22 copy & paste +upvote -downvote 🥁Thrilled to announce that our paper is out @NatureMedicine! We looked at the impact of nivolumab/ipilimumab +/-… https://t.co/8iCamY8G6S
9.
RenoHemonc
Santhosh Ambika @RenoHemonc
BFAST cohort C #ESMO21 was negative trial to liquid 🩸 biopsy. Be SLOW to wait test solid tumor. Liquid biopsy i… twitter.com/i/web/status/1…
Retweet of status by @FernandoOnco
20 Sep 21 copy & paste +upvote -downvote ⚠️BFAST cohort C #ESMO21 was negative ➖ trial to liquid 🩸 biopsy. Be SLOW to wait test solid tumor. Liquid biopsy i… https://t.co/gJa91q6aoR

...but wait! There's more!

1.

fakhright
fakhright @fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
14 Jan 13 copy & paste +upvote -downvote astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat* 🙈🙈🙊
https://www.iemoji.com/feed/RenoHemonc
Back to top